Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesMycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohns disease
Inflammatory Bowel Disease, 10/14/09
Shanahan F et al. – Increased proliferation of T cells and an altered cytokine response suggest that prior exposure to MAP and engagement of the immune system is common in patients with CD. This does not imply causation but does support further examination of this bacterium as an environmental modifying factor.
Related Articles
A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09
Relevance Score: 69%
Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09
Relevance Score: 69%
Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohns disease
Inflammatory Bowel Disease, 11/05/09
Relevance Score: 69%
C-Reactive Protein and Disease Activity in Children with Crohns Disease
Digestive Diseases and Sciences, 10/26/09
Relevance Score: 69%
Malignant Transformation in Perianal Fistulas of Crohns Disease: a Systematic Review of Literature
Journal of Gastrointestinal Surgery, 10/21/09
Relevance Score: 69%
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis
Alimentary Pharmacology and Therapeutics, 12/17/09
Mechanical bowel preparation does not affect the intramucosal bacterial colony count
International Journal of Colorectal Disease, 12/17/09
The effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study
Alimentary Pharmacology and Therapeutics, 12/17/09
Article Search
Sponsor